Response to: Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years' by Yamamoto et al

John H. Stone, Mollie N. Carruthers, Mark D. Topazian, Arezou Khosroshahi, Thomas E. Witzig, Zachary S. Wallace, Phillip A. Hart, Vikram Deshpande, Thomas C. Smyrk, Suresh Chari

Research output: Contribution to journalLetterpeer-review

2 Scopus citations
Original languageEnglish (US)
Article numberA34
JournalAnnals of the rheumatic diseases
Volume74
Issue number8
DOIs
StatePublished - Aug 1 2015

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology
  • Rheumatology
  • Immunology and Allergy
  • Immunology

Cite this